when intellia therapeutics submit bla for lonvo-z
before October
when intellia therapeutics submit bla for lonvo-z. Best Yes near 60¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 60¢ · Best No: 50¢ · 1 platform
- Kalshi: Yes 60¢ / No 50¢
LIVE
before October
Volume
$644
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Oct 1, 2026
~108 days left
Category
Culture
Yes
60¢
Kalshi
No
50¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Oct 1, 2026, then the market resolves to Yes.
Market Details
ResolutionResolves Oct 1, 2026
Time Left108 days
Status● Active
CategoryCulture
Yes
60¢
Kalshi
Payout 1.7x
No
50¢
Kalshi
Payout 2.0x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In